Rockefeller Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40
| Closed | – | – | 3832 |
|
|
2022
Q4 | $0 | Hold |
40
| – | – | ﹤0.01% | 4238 |
|
|
2022
Q3 | $0 | Sell |
40
-31
| -44% | – | ﹤0.01% | 4410 |
|
|
2022
Q2 | $0 | Sell |
71
-52
| -42% | – | ﹤0.01% | 4413 |
|
|
2022
Q1 | $1K | Sell |
123
-581
| -83% | -$4.72K | ﹤0.01% | 3791 |
|
|
2021
Q4 | $11K | Buy |
704
+504
| +252% | +$7.88K | ﹤0.01% | 2948 |
|
|
2021
Q3 | $3K | Hold |
200
| – | – | ﹤0.01% | 3368 |
|
|
2021
Q2 | $4K | Buy |
+200
| New | +$4K | ﹤0.01% | 3114 |
|
|
2021
Q1 | – | Sell |
-500
| Closed | -$6K | – | 3401 |
|
|
2020
Q4 | $6K | Hold |
500
| – | – | ﹤0.01% | 2402 |
|
|
2020
Q3 | $4K | Sell |
500
-59
| -11% | -$472 | ﹤0.01% | 2306 |
|
|
2020
Q2 | $6K | Sell |
559
-109
| -16% | -$1.17K | ﹤0.01% | 2063 |
|
|
2020
Q1 | $7K | Hold |
668
| – | – | ﹤0.01% | 1868 |
|
|
2019
Q4 | $11K | Buy |
668
+133
| +25% | +$2.19K | ﹤0.01% | 1595 |
|
|
2019
Q3 | $7K | Sell |
535
-35
| -6% | -$458 | ﹤0.01% | 1544 |
|
|
2019
Q2 | $8K | Sell |
570
-370
| -39% | -$5.19K | ﹤0.01% | 1331 |
|
|
2019
Q1 | $17K | Buy |
+940
| New | +$17K | ﹤0.01% | 1316 |
|